Answers are grounded in this paper and cite their sources.
Despite the importance of antimicrobial susceptibility testing (AST) for clinical management of infection and antimicrobial resistance (AMR) surveillance, the methodologies and breakpoints of the two most commonly used systems worldwide, Clinical and Laboratory Standards Institute (CLSI) and European Committee for Antimicrobial Susceptibility Testing (EUCAST), are far from harmonized. Both systems are recommended in the World Health Organization's Global Antimicrobial Resistance Surveillance System (GLASS) [1]), but how discrepancies between the two systems will be addressed is unclear.
No takes yet. Share an insight, caveat, or question.
Cusack et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: